3-36991692-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_014805.4(EPM2AIP1):c.1386G>A(p.Met462Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,612,826 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014805.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EPM2AIP1 | ENST00000322716.8 | c.1386G>A | p.Met462Ile | missense_variant | Exon 1 of 1 | 6 | NM_014805.4 | ENSP00000406027.1 | ||
EPM2AIP1 | ENST00000624586.1 | c.387+189G>A | intron_variant | Intron 1 of 1 | 5 | ENSP00000485091.1 | ||||
EPM2AIP1 | ENST00000623924.1 | c.62+1186G>A | intron_variant | Intron 1 of 2 | 5 | ENSP00000485489.1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152158Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000525 AC: 13AN: 247546 AF XY: 0.0000372 show subpopulations
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1460668Hom.: 0 Cov.: 33 AF XY: 0.00000826 AC XY: 6AN XY: 726680 show subpopulations
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152158Hom.: 0 Cov.: 33 AF XY: 0.0000942 AC XY: 7AN XY: 74340 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1386G>A (p.M462I) alteration is located in exon 1 (coding exon 1) of the EPM2AIP1 gene. This alteration results from a G to A substitution at nucleotide position 1386, causing the methionine (M) at amino acid position 462 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at